Last reviewed · How we verify
NCT05674734: A4FM/AE
4FM Acceptance Training as the New Form of cPTSD-focused Treatment Based on Existential Analysis
NA trial testing 4FM Acceptance Training in Trauma in 100 participants. Not yet recruiting.
30 June 2023
Quick facts
| Lead sponsor | Institute of Psychiatry and Neurology, Warsaw |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 April 2023 |
| Primary completion | 30 June 2023 |
| Estimated completion | 31 December 2026 |
Drugs / interventions tested
- 4FM Acceptance Training
Conditions studied
- Trauma — all drugs for Trauma →
Sponsor
Institute of Psychiatry and Neurology, Warsaw
Who can join
Adults 18 to 60, any sex, with Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Research project entitled "The experience of relational trauma as an important etiological factor of neurotic and/or personality disorders. The 4FM Acceptance training as a new form of therapy for these disorders" assumes the following goals: 1. validation of the Polish version of the International Trauma Questionnaire (ITQ); 2. assessment of prevalence of relational trauma among adult psychiatric patients hospitalized at the Institute of Psychiatry and Neurology; 3. development a new therapeutic intervention - 4FM Acceptance training - based on the methodology of the Existential Analysis; 4. assessment of the impact of the 4FM Acceptance training among patients with cPTSD. The original therapeutic intervention - 4FM Acceptance training - will be developed based on the methodological assumptions of the 4 Fundamental Motivations (4FM) in the Existential Analysis methodology, developed by Alfried Längle, student of Viktor Frankl, a representative of the Existential Psychology, together with other important representatives, i.e. Rollo May, Irvin Yalom and in Poland prof. Antoni Kępiński.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05674734
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trauma
Currently open trials in the same condition.
- NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
- NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
- NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
- NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
- NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting
Other Institute of Psychiatry and Neurology, Warsaw trials
Trials by the same sponsor.
- NCT05961644 — Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). · Phase 2, PHASE3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05674734 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute of Psychiatry and Neurology, Warsaw
- Last refreshed: 6 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05674734.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing